Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. The firm is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
437
Frequently Asked Questions
What is Market Cap of Crinetics Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Crinetics Pharmaceuticals Inc market cap is $3.18B.
What is the 52-week high for Crinetics Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Crinetics Pharmaceuticals Inc 52 week high is $62.53 as of September 16, 2025.
What is the 52-week low for Crinetics Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Crinetics Pharmaceuticals Inc 52 week low is $24.10 as of September 16, 2025.
What is Crinetics Pharmaceuticals Inc stock price today?
Crinetics Pharmaceuticals Inc stock price today is $34.10.
What was Crinetics Pharmaceuticals Inc stock price yesterday?
Crinetics Pharmaceuticals Inc stock price yesterday was $33.77.
What is the PE ratio of Crinetics Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Crinetics Pharmaceuticals Inc’s P/E ratio is -8.21.
What is the Price-to-Book ratio of Crinetics Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Crinetics Pharmaceuticals Inc P/B ratio is 2.7132.
What is the 50-day moving average of Crinetics Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Crinetics Pharmaceuticals Inc 50-day moving average is $30.99.
How many employess does Crinetics Pharmaceuticals Inc has?